Stem cells have gained attention as a promising therapeutic approach for damaged myocardium, and there have been efforts to develop a protocol for regenerating cardiomyocytes (CMs). Certain cells have showed a greater aptitude for yielding beating CMs, such as induced pluripotent stem cells, embryonic stem cells, adipose-derived stromal vascular fraction cells and extended pluripotent stem cells. The approach for generating CMs from stem cells differs across studies, although there is evidence that Wnt signaling, chemical additives, electrical stimulation, co-culture, biomaterials and transcription factors triggers CM differentiation. Upregulation of Gata4, Mef2c and Tbx5 transcription factors has been correlated with successfully induced CMs, although Mef2c may potentially play a more prominent role in the generation of the beating phenotype, specifically. Regenerative research provides a possible candidate for cardiac repair; however, it is important to identify factors that influence their differentiation. Altogether, the spontaneously beating CMs would be monumental for regenerative research for cardiac repair.
Keyphrases
- stem cells
- transcription factor
- induced apoptosis
- cell therapy
- cell cycle arrest
- embryonic stem cells
- mesenchymal stem cells
- high glucose
- tissue engineering
- induced pluripotent stem cells
- randomized controlled trial
- left ventricular
- signaling pathway
- spinal cord injury
- cell proliferation
- cell death
- endothelial cells
- pluripotent stem cells
- dna binding
- bone marrow
- poor prognosis
- ionic liquid
- acute kidney injury
- quality improvement
- pi k akt
- cardiac surgery
- atrial fibrillation
- genome wide identification